Biocryst Pharmaceuticals (BCRX) Assets Average: 2011-2015
Historic Assets Average for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to $144.6 million.
- Biocryst Pharmaceuticals' Assets Average rose 3.60% to $144.6 million in Q3 2015 from the same period last year, while for Sep 2015 it was $144.6 million, marking a year-over-year increase of 3.60%. This contributed to the annual value of $92.9 million for FY2014, which is 74.72% up from last year.
- Per Biocryst Pharmaceuticals' latest filing, its Assets Average stood at $144.6 million for Q3 2015, which was up 3.25% from $140.0 million recorded in Q2 2015.
- Biocryst Pharmaceuticals' 5-year Assets Average high stood at $144.6 million for Q3 2015, and its period low was $43.4 million during Q2 2013.
- In the last 3 years, Biocryst Pharmaceuticals' Assets Average had a median value of $92.7 million in 2014 and averaged $93.3 million.
- Its Assets Average has fluctuated over the past 5 years, first plummeted by 44.46% in 2013, then surged by 199.72% in 2014.
- Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Assets Average stood at $87.4 million in 2011, then crashed by 30.44% to $60.8 million in 2012, then declined by 16.01% to $51.0 million in 2013, then soared by 168.44% to $137.0 million in 2014, then rose by 3.60% to $144.6 million in 2015.
- Its last three reported values are $144.6 million in Q3 2015, $140.0 million for Q2 2015, and $133.4 million during Q1 2015.